HCV Eradication by DAAs Improves Glucose Tolerance HCV Eradication by DAAs Improves Glucose Tolerance
Chronic HCV genotype 1 is associated with a higher incidence of type 2 diabetes in its advanced stages. Could early HCV eradication improve glucose tolerance in patients with HCV-related cirrhosis?Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Cirrhosis | Diabetes | Diabetes Type 2 | Endocrinology | Gastroenterology | Health | Liver | Urology & Nephrology